Literature DB >> 16024122

Interactions of the integrin subunit beta1A with protein kinase B/Akt, p130Cas and paxillin contribute to regulation of radiation survival.

Julia Seidler1, Rita Durzok, Cord Brakebusch, Nils Cordes.   

Abstract

BACKGROUND AND
PURPOSE: Cell adhesion-mediated radioresistance is a common phenomenon particularly relevant in tumor cells, which might hamper anticancer therapies. To analyze the role of adhesion-mediating beta1-integrins, stably transfected functional beta1A-integrin-expressing GD25beta1A and GD25beta1B cells, which express mutant beta1B-integrins, were compared in terms of radiation survival and beta1-integrin signaling.
MATERIALS AND METHODS: Cells grown on fibronectin, collagen-III, laminin, vitronectin, anti-beta1-integrin-IgG (beta1-IgG) or poly-l-lysine were irradiated with 0-6Gy in presence or absence of growth factors or inhibitors for phosphatidylinositol-3 kinase (PI3K), i.e. Ly294002 and wortmannin. In addition to colony formation, protein kinase B/Akt (PKB/Akt) kinase activity, focal adhesion kinase (FAK), p130Cas, paxillin and c-Jun N2-terminal kinase (JNK) expression and phosphorylation were analyzed by Western blot technique.
RESULTS: Adhesion of GD25beta1A cells to extracellular matrix proteins or beta1-IgG resulted in growth factor-independent radiation survival. In contrast, serum starved GD25beta1B cells showed a significant (P<0.01) reduction in radiation survival on all substrates. PI3K inhibition moderately or strongly radiosensitized GD25beta1A or GD25beta1B cells, respectively. The pro-survival effects detected in serum starved GD25beta1A cells were due to direct, PI3K-mediated stimulation of PKB/Akt activity by beta1-integrins and induced p130Cas and paxillin phosphorylation. Phosphorylated p130Cas and paxillin subsequently prevented activation of cell death-regulating JNK.
CONCLUSIONS: The data show that beta1-integrin-mediated signaling through the cytoplasmic integrin domains is critical for efficient pro-survival regulation after irradiation. Profound knowledge of the underlying mechanisms of integrin-mediated cellular radioresistance could foster the design of new molecular-targeted anticancer therapies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024122     DOI: 10.1016/j.radonc.2005.06.018

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Phosphatase and Tensin Homolog (PTEN) Represses Colon Cancer Progression through Inhibiting Paxillin Transcription via PI3K/AKT/NF-κB Pathway.

Authors:  Ling-Li Zhang; Gang-Gang Mu; Qian-Shan Ding; Yan-Xia Li; Yun-bo Shi; Jin-Fen Dai; Hong-Gang Yu
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

2.  RAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  Prostate       Date:  2014-08-11       Impact factor: 4.104

3.  Molecular imprinting as a tool for determining molecular markers: a lung cancer case.

Authors:  Elena Piletska; Kirabo Magumba; Lesslly Joseph; Alvaro Garcia Cruz; Rachel Norman; Rajinder Singh; Antonella F S Tabasso; Donald J L Jones; Salvador Macip; Sergey Piletsky
Journal:  RSC Adv       Date:  2022-06-15       Impact factor: 4.036

Review 4.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

5.  Propofol inhibits pressure-stimulated macrophage phagocytosis via the GABAA receptor and dysregulation of p130cas phosphorylation.

Authors:  Hiroe Shiratsuchi; Yasser Kouatli; Guang Xiang Yu; Harold M Marsh; Marc D Basson
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-08       Impact factor: 4.249

6.  β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1.

Authors:  Hira Lal Goel; Aejaz Sayeed; Michael Breen; Matthew J Zarif; David S Garlick; Irwin Leav; Roger J Davis; Thomas J Fitzgerald; Andrea Morrione; Chung-Cheng Hsieh; Qin Liu; Adam P Dicker; Dario C Altieri; Lucia R Languino
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

7.  Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.

Authors:  Catherine C Park; Hui J Zhang; Evelyn S Yao; Chong J Park; Mina J Bissell
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

Review 8.  Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy.

Authors:  Byeong Mo Kim; Yunkyung Hong; Seunghoon Lee; Pengda Liu; Ji Hong Lim; Yong Heon Lee; Tae Ho Lee; Kyu Tae Chang; Yonggeun Hong
Journal:  Int J Mol Sci       Date:  2015-11-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.